Cargando…
Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
Vincristine is an antineoplastic substance that is part of many chemotherapy regimens, used especially for the treatment of a variety of pediatric cancers including leukemias and brain tumors. Unfortunately, many vincristine-treated patients develop peripheral neuropathy, a side effect characterized...
Autores principales: | Starobova, H., Mueller, A., Allavena, R., Lohman, R. J., Sweet, M. J., Vetter, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610325/ https://www.ncbi.nlm.nih.gov/pubmed/31316337 http://dx.doi.org/10.3389/fnins.2019.00653 |
Ejemplares similares
-
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017) -
Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
por: Starobova, Hana, et al.
Publicado: (2021) -
Subcutaneous ω-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy
por: Hasan, Md. Mahadhi, et al.
Publicado: (2021) -
Prevention of Paclitaxel-induced allodynia by Minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats
por: Liu, Cui-Cui, et al.
Publicado: (2010) -
Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
por: Wright, Galen E.B., et al.
Publicado: (2018)